Fierce Biotech: Iambic Ups Rhythm in AI-enabled Race to Clinic, Revealing $100M Round and Nvidia Pact
Press
This is some text inside of a div block.
October 4, 2023
Related announcements
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Podcast Discusses New Advances for Iambic's Clinical Oncology Study and its AI-Driven Drug Discovery Platform
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Iambic Therapeutics to Present New Pre-Clinical Data for IAM1363, a Selective and Brain-Penetrant Inhibitor of both HER2 Wild-Type and Oncogenic Mutants, at the 2024 AACR Annual Meeting